Neurofilament Light Chain as a Biomarker in Multiple Sclerosis
Open Access
- 5 April 2019
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 10, 338
- https://doi.org/10.3389/fneur.2019.00338
Abstract
Due to the unpredictable course and heterogenous treatment response in multiple sclerosis (MS), there is a clear need for biomarkers that reflect disease activity in the clinical follow-up of these patients. Neurofilaments are neuron-specific components of the cytoskeleton that can be assayed in different body compartments. They have been explored as potential biomarkers for many years. Neurofilament light chain (NF-L) appears the most promising biomarker in MS patients, and there is now little doubt that NF-L should have a role in the follow-up of MS patients. Newer assays and techniques for NF-L detection available in serum samples confirms the usefulness of NF-L as a biomarker. Nevertheless, there is still a need for prospective studies, and studies to determine clinical useful cut-off values. This review evaluates the strengths and weaknesses of NF-L as a biomarker in patients with MS.Keywords
This publication has 56 references indexed in Scilit:
- Paraneoplastic neuronal intermediate filament autoimmunityNeurology, 2018
- Serum neurofilament lightNeurology, 2018
- Multicenter evaluation of neurofilaments in early symptom onset amyotrophic lateral sclerosisNeurology, 2018
- Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosisAnnals of Neurology, 2017
- Neurofilament light chain: a biomarker for genetic frontotemporal dementiaAnnals of Clinical and Translational Neurology, 2016
- Axonal transport and neurodegenerative diseaseBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2006
- The cytoskeleton in neurodegenerative diseasesThe Journal of Pathology, 2004
- Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple sclerosisJournal of Neurology, Neurosurgery & Psychiatry, 1998
- Patients with Amyotrophic Lateral Sclerosis and Other Neurodegenerative Diseases Have Increased Levels of Neurofilament Protein in CSFJournal of Neurochemistry, 1996
- Quantitative and Qualitative Alterations of Neuronal and Glial Intermediate Filaments in Rat Nervous System After Exposure to 2, 5‐HexanedioneJournal of Neurochemistry, 1991